Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression

Alan Belicha-Villanueva1, Juan R Rodriguez-Madoz, Jad Maamary

  • 1Department of Microbiology, Mount Sinai School of Medicine, New York, New York, USA.

Journal of Virology
|March 9, 2012
PubMed

Insights

Influenza A viruses with specific promoter mutations show increased protein expression but reduced replication. This suggests a balance is needed between viral replication, protein production, and particle assembly for effective influenza virus function.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Influenza A virus relies on precise regulation of viral gene expression for replication and pathogenesis.
  • Understanding promoter elements is crucial for manipulating viral behavior.

Purpose of the Study:

  • To investigate the impact of specific promoter mutations (G3A/C8U) on Influenza A virus replication and protein expression.
  • To explore the relationship between viral RNA levels, protein production, and viral particle assembly.

Main Methods:

  • Construction of recombinant Influenza A viruses with G3A/C8U promoter mutations.
  • Analysis of viral mRNA, cRNA, and protein expression levels during infection.
  • Assessment of viral replication kinetics and particle shedding.

Main Results:

  • Mutations G3A/C8U in the viral promoter led to significantly increased levels of viral mRNA, cRNA, and corresponding proteins.
  • Recombinant viruses exhibited attenuated replication compared to wild-type viruses.
  • Enhanced shedding of noninfectious viral particles was observed.
  • The mutant viruses showed impaired ability to antagonize the host interferon response.

Conclusions:

  • Specific promoter mutations can enhance viral protein expression in Influenza A virus.
  • A delicate balance exists between viral replication, protein expression, and assembly, which can be disrupted by promoter mutations.
  • These findings offer insights into potential strategies for controlling influenza virus through genetic manipulation.